Page 303 of 345: studies 3,021 to 3,030 of 3,446, newest first. Back to the MDMA overview
Libro Comunicaciones 2021
Descripción del caso: Mujer de 30 años traída a Urgencias tras encontrarla andando por la carretera. Hace 48h se encontraba en un retiro espiritual, consumiendo una cantidad indeterminada de ayahuasca. Ha permanecido en vigilia desde el consumo, con sensación de que si acaba cerrando los ojos puede morir. Se encuentra inquieta, con desinhibición conductual y en contexto de elevada angustia, se...
FOCUS: The Journal of Lifelong Learning in Psychiatry 2021 Collin Reiff, Elon E. Richman, Charles B. Nemeroff et al. 17 citations
Objective: The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders. Methods: Searches of PubMed and PsycINFO via Ovid were conducted for articles in English, in peer-reviewed journals, reporting on “psilocybin,” “lysergic acid diethylamide,” “LSD,” “ayahuasca,” “3,4-methylenedioxymethamphetamine,” and “MDMA,” in...
Figshare 2021 Jeremy Weleff, Teddy J. Akiki, Brian S. Barnett preprint
Dataset for a bibliometric analysis of journal articles reporting findings from clinical studies of the psychedelics 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT), ayahuasca, dimethyltryptamine (DMT), ibogaine, lysergic acid diethylamide (LSD), mescaline, MDMA, and psilocybin published from 1965-2018.This data accompanies our article:Bibliometric Analysis of Academic Journal Articles Reporting...
Dissent 2021 Sophie Pinkham 1 citation
The Problem of Pain Sophie Pinkham (bio) White Market Drugs: Big Pharma and the Hidden History of Addiction in America by David Herzberg University of Chicago Press, 2020, 400 pp. Click for larger view View full resolution A worker removes the Sackler name from a building at Tufts University in 2019. (David L. Ryan/The Boston Globe via Getty Images) [End Page 130] Reams have been written about...
European Addiction Research 2021 Matthijs Blankers, Daan van der Gouwe, Lavinia Stegemann et al. 21 citations
In this article, we present an evaluation of online psychoactive substance trade via Telegram, a free encrypted social media messenger service. The evaluation took place during the COVID-19 pandemic, which allowed us to monitor the effects of the spring 2020 lockdown in the Netherlands on substance trade via Telegram. The objective of this study was to evaluate whether changes in psychoactive...
Neurotoxicity Research December 18, 2020 Adam Wojtas, Monika Herian, Mateusz Skawski et al. 33 citations
Abstract 4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) is a hallucinogen exhibiting high binding affinity for 5-HT 2A/C serotonin receptors. In the present work, we investigated its effect on dopamine (DA), serotonin (5-HT), acetylcholine (ACh), and glutamate release in the rat frontal cortex, striatum, and nucleus accumbens. Hallucinogenic activity, impact on cognitive...
Pharmacological Reviews December 16, 2020 Antonio Inserra, Danilo de Gregorio, Gabriella Gobbi 227 citations
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug Administration in a new class of antidepressants, and 3,4-methylenedioxymethamphetamine (MDMA) is undergoing phase III clinical trials for post-traumatic stress disorder. Psilocybin and lysergic acid diethylamide (LSD) are being...
Frontiers in Psychiatry December 10, 2020 Ove Heradstveit, Jens Christoffer Skogen, Marit Edland-Gryt et al. 19 citations
Background and Aims: Several studies have pointed to relatively high levels of illicit drug use among students in higher education compared to the general population. The aim of the present study was to provide an updated examination of self-reported illicit drug use among Norwegian University and college students. Methods: Data stem from the SHoT study (Students' Health and Well-being Study),...
Drugs Education Prevention and Policy December 10, 2020 Monnica T. Williams, Alan K. Davis, Yitong Xin et al. 100 citations
This study examined how psychedelics reduced symptoms of racial trauma among black, indigenous, and people of color (BIPOC) subsequent to an experience of racism. A cross-sectional internet-based survey included questions about experiences with racism, mental health symptoms, and acute and enduring psychedelic effects. Changes in mental health were assessed by retrospective report of symptoms...
Psychopharmacology December 2020 Simon D. Brandt, Hailey M Walters, John S. Partilla et al.
The nonmedical use of new psychoactive substances (NPS) is a worldwide public health concern. The so-called "benzofury" compounds, 5-(2-aminopropyl)benzofuran (5-APB) and 6-(2-aminopropyl)benzofuran (6-APB), are NPS with stimulant-like properties in human users. These substances are known to interact with monoamine transporters and 5-HT receptors in transfected cells, but less is known about...